Financing, Equity Capital Markets

BioCryst Pharmaceuticals, Inc.

05/20
|
$100.0 Million
Piper Sandler served as bookrunner for BioCryst Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma